Top

Published in:

01-10-2007 | Abstracts

Oral Presentations

Authors: J. McEwen, I. W. Boyd

Published in: Drug Safety | Issue 10/2007

Excerpt

A World Health Organization consultation[1] in 2006 has recommended, amongst other things, that countries are encouraged to report adverse events following immunisation (AEFI) through their government’s designated national pharmacovigilance centre. In Australia, the primary point for submission and initial assessment of reports of AEFIs was changed to be the Adverse Drug Reactions Advisory Committee (ADRAC), in whose name the national pharmacovigilance centre has functioned since 1971. The work of ADRAC is supported by an Adverse Drug Reactions Unit in the Australian Department of Health. …

WHO consultation on global monitoring of adverse effects following immunization, 9–10 January 2006. Weekly Epidemiological Record 2006; 81 (27): 261–6

Isaacs D, Lawrence G, Boyd I, et al. Reporting of adverse events following immunisation in Australia. J Paediatr Child Health 2005; 41: 163–6PubMedCrossRef

Australian Adverse Drug Reactions Bulletin 2001; 20: 10

Title: Oral Presentations
Authors: J. McEwen
I. W. Boyd
Publication date: 01-10-2007
Publisher: Springer International Publishing
Published in: Drug Safety / Issue 10/2007
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI: https://doi.org/10.2165/00002018-200730100-00029

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Oral Presentations

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2007

Poster Presentations